Paragon BioTeck, Inc. Receives FDA Clearance for Comfortear Lacrisolve Absorbable Punctum Plug

| From
Photo: Comfortear Lacrisolve

PORTLAND, Ore., June 25, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear® Lacrisolve™ Absorbable Punctum Plug.

"Receiving FDA 510(k) clearance for this device is an important milestone for Paragon. Dry eye affects over 4.8 million people in the U.S. and, keeping with Paragon's ultimate goal to protect and preserve eyesight, the Comfortear Lacrisolve Absorbable Punctum Plug is a great addition to our portfolio of FDA regulated ophthalmic products," says Lauren M-C Bluett, Director of Quality Assurance.

About Comfortear® Lacrisolve™ Absorbable Punctum Plug:

Comprised of the synthetic absorbable polymer, polydioxanone, the Comfortear® Lacrisolve™ Absorbable Punctum Plugs are medium-term implants designed to be inserted into the canaliculus in order to block tear drainage through the lacrimal drainage system. The Comfortear® Lacrisolve™ Absorbable Punctum Plugs are available in two diameters: 0.4mm and 0.5mm. The implants are supplied sterile with two implants per package.

Absorption time for the Comfortear® Lacrisolve™ Absorbable Punctum Plugs is approximately 6 months (=<6). For full prescribing information, visit

Product Availability:

The Comfortear® Lacrisolve™ Absorbable Punctum Plugs will ship July 2014. To preorder or learn more about Paragon's products, call 888-424-1192. Product orders or inquiries can also be sent to

For up to date information on Paragon BioTeck, Inc., subscribe to its newsletter to receive important information regarding the product launch, special offers and more.

About Paragon BioTeck, Inc.:

Paragon BioTeck is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.

For more information on the company and its work, please visit or call 888-424-1192; or email

*Photo Caption: Comfortear® Lacrisolve™ Absorbable Punctum Plugs.

Twitter: @paragonbioteck

News Source:
For more information regarding this press release, please visit:
Like, Share, Save this press release:
  TWEET   SHARE   G+   PIN IT   STUMBLE   LinkedIn   Instapaper   Buffer

Shortlink to this press release:
The content of the above press release was provided by the “news source” (Paragon BioTeck, Inc.) or authorized agency, who is solely responsible for its accuracy. Send2Press® is the originating wire service for this story and content is Copr. © 2014 Paragon BioTeck, Inc. with newswire version Copr. © 2014 Send2Press (a service of Neotrope). All trademarks acknowledged.

Rights granted for reproduction by any legitimate news organization. However, if news is cloned/scraped verbatim, then original attribution must be maintained with link back to this page as “original syndication source.” Resale of this content for commercial purposes is prohibited without a license. Reproduction on any site selling a competitive service is also prohibited. Information is believed accurate, as provided by news source or authorized agency, however is not guaranteed, and you assume all risk for use of any information found herein/hereupon. This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
STORY READS for this single page only, as of Oct 22 2016:
[ count retired 8.4.16 ]

back to top
REFERENCES: Comfortear Lacrisolve, pharmaceuticals, ophthalmic pharmaceuticals, Comfortear Lacrisolve Absorbable Punctum Plug, news, press release from Paragon BioTeck, Inc., Jun 25, 2014, Devices and Research, Medical, Product Launches, Portland, Oregon, Paragon BioTeck, Inc. Receives FDA Clearance for Comfortear Lacrisolve Absorbable Punctum Plug